SAVED
File name .JPG
File alt. text
Image should be px wide x px tall.
Select Image
home - Pancreas - Pancreatic Masses and Cysts - IPMN Written by Dr Sebastian Zeki

IPMN

Intraductal papillary mucinous neoplasm= =IPMT/ IPMN Mucin Histological Features:Dilated ductal segments with mucous secreting cells.It is usually within the head of the pancreas and progresses distally.It is localised or diffuse .If involves mall branch ducts = BDT-IPMN, if main duct= MDT-IPMN. IPMN Cancer Adenoma to carcinoma sequence- 10 to 15 years High malignant potential. PrognosisThere is a 70 % 3-year survival overall for IPMN with a cancer.Patients with BDT-IPMN do better than those with MDT-IPMN. Features Suggesting malignancy:A main pancreatic duct >10 mm.Cystic lesion >30 mm with irregular, thick septum.Mural nodules >10 mm. MDT-IPMN (75%)Start in head and progress distallyMore aggressive BDT-IPMNStart in uncinate/ tail.Less likely to be malignant TreatmentResect if suspicious features for malignancy. Histological Subtypes:Intestinal-type IPMN-more show moderate or high-grade dysplasia.Main ducts>side branches.Gastric-type IPMN- typically show no > low grade dysplasia.Side branches >main duct.Pancreatobiliary-type IPMN-show high grade dysplasia and are considered to have high malignant potential.Oncocytic type IPMN-typically exhibit high grade dysplasia.Tubular type IPMN - rare and are usually low grade. Endoscopic retrograde cholangiopancreatogra-phy (ERCP) — Filling defectsFish-eye papilla with mucus extruding from the orifice.Endoscopic ultrasound (EUS) — Segmental or diffuse dilation of the main pancreatic duct with the presence of intraductal (mural) nodules in MDT-IPMNMultiple small cysts (5 to 20 mm) in BDT-IPMNCan be helpful to distinguish from chronic pancreatitisPancreatoscopy — Intraductal ultrasound —For tumour extent in MDT-IPMNCT scan and magnetic resonance imaging — A CT scan finding of >3 mm mural nodules within a cyst or the duct is highly suggestive of malignancy MRP is better than ERCP but not at looking at peripheral ducts. Aetiology And Pathogenesis-K-ras mutations are found in 50%.-P53 overexpression occurs late in IPMN during the progression to cancer.-DPC4 (deleted in pancreatic cancer) is expressed in all cases of IPMN vs 50% inactivation in traditional pancreatic ductal cancer.-MUC2 mucin and MUC5 mucin mRNA are highly expressed in IPMN. Clinical PresentationIt presents at 60-70 years.Previous acute panc or chronic obstruc-tive pancreatitis is a risk.CA 19-9 and CEA are usually normal. (in order of frequency) Diagnosis Written by Dr Sebastian Zeki

Related Stories

•Artificial intelligence-based analysis of time-lapse images of sphere formation and process of plate adhesion and spread of pancreatic cancer cells

•Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications including needle tract seeding

•Endoscopic Ultrasound in Pancreatology: Focus on Inflammatory Diseases and Interventions

•Diagnostic Endoscopic Ultrasound in Pancreatology: Focus on Normal Variants and Pancreatic Masses

•Mediastinal extension of pancreatic pseudocysts causing portal hypertension